Gene Chips Advance Medical Research

The Washington Times (Washington, DC), June 13, 2005 | Go to article overview

Gene Chips Advance Medical Research


Byline: Joyce Howard Price, THE WASHINGTON TIMES

Gene chips, DNA scanning devices that can sort millions of fragments of genetic information, are a major advance in personalizing disease diagnoses and medical treatments, based on differences in each patient's genes.

The thin glass chips, widely used in research laboratories for the past five years, may be commonplace in clinical practice in the not-too-distant future. They allow scientists to analyze thousands of human genes or gene fragments at once, rather than individually, so disease causes can be identified and therapies quickly applied.

Now some American scientists who have been on the cutting edge of this technology say it's time to develop international standards for the use of the tools, also known as DNA microarrays.

Last month, more than 40 scientists, including some from the U.S. Department of Health and Human Services and several from Europe and Asia, met in Paris to brainstorm this issue.

"International standardization has to happen. If not, it will hold back modern medicine, because all medical research is focused on using genomic tools for early diagnosis and treatment," said Dietrich Stephan, director of the neurogenomics division at the nonprofit Translational Genomics Research Institute, or TGen, in Phoenix.

Mr. Stephan said he is taking that position, even though the "vast majority of gene-chip use [to date] has been as a research tool," rather than in clinical practice.

He predicts global standards for assessing the technical performance of these chips will be in place in a year or two.

Janet Warrington, vice president of emerging markets and molecular diagnoses at Affymetrix, Inc., a Santa Clara, Calif.-based firm that has been a leader in gene-chip research, believes that prediction is entirely possible.

Reasons for optimism

"This is a force that's happening now. There are standard controls in development now, and it's an international effort," said Ms. Warrington, who organized and chaired the meeting in Paris.

Ira Lubin, a geneticist at the federal Centers for Disease Control and Prevention in Atlanta, who also attended the meeting, said in an interview there are "many reasons to be very optimistic" about the outlook for clinical effectiveness of DNA microarrays, based "on the work that already has been done." He termed the time frame Ms. Warrington and Mr. Stephan suggested for international standards to be in place "quite reasonable."

Officials of Affymetrix, co-developers of a DNA microarray test that's been approved by the U.S. Food and Drug Administration, identified two international organizations - the Organization for Economic Cooperation and Development (OECD) and the Clinical and Laboratory Standards Institute (CLSI) - involved in this movement.

Relapse predicted, avoided

CLSI, a nonprofit group, is "at work designing a clinical protocol," Ms. Warrington said in a telephone interview.

Mr. Stephan and other researchers atTGen have used gene chips to help determine the chances of relapse in children whose leukemia is in remission and to help select the best therapies for other cancer patients.

Mr. Stephan cites one man who, three years ago, was "on his deathbed with pancreatic cancer," one of the deadliest forms of cancer. By monitoring the patient's gene activity with DNA chips, Mr. Stephan said, it appeared he could benefit from a drug commonly used to treat breast cancer. The patient was put on that regimen.

"Today, he is healthy as a horse," the researcher said.

Ethical issues possible

No one is saying DNA-based medical testing is always so beneficial. Research is still under way to determine its effectiveness, and, increasingly, it's being tested in clinical trials.

"The bottom line is that we want to ensure that there is an appropriate level of quality" in DNA-based medical testing, as in other medical testing, said Mr. …

The rest of this article is only available to active members of Questia

Sign up now for a free, 1-day trial and receive full access to:

  • Questia's entire collection
  • Automatic bibliography creation
  • More helpful research tools like notes, citations, and highlights
  • Ad-free environment

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
One moment ...
Default project is now your active project.
Project items

Items saved from this article

This article has been saved
Highlights (0)
Some of your highlights are legacy items.

Highlights saved before July 30, 2012 will not be displayed on their respective source pages.

You can easily re-create the highlights by opening the book page or article, selecting the text, and clicking “Highlight.”

Citations (0)
Some of your citations are legacy items.

Any citation created before July 30, 2012 will labeled as a “Cited page.” New citations will be saved as cited passages, pages or articles.

We also added the ability to view new citations from your projects or the book or article where you created them.

Notes (0)
Bookmarks (0)

You have no saved items from this article

Project items include:
  • Saved book/article
  • Highlights
  • Quotes/citations
  • Notes
  • Bookmarks
Notes
Cite this article

Cited article

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

(Einhorn, 1992, p. 25)

(Einhorn 25)

1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited article

Gene Chips Advance Medical Research
Settings

Settings

Typeface
Text size Smaller Larger Reset View mode
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

Full screen

matching results for page

Cited passage

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn, 1992, p. 25).

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn 25)

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences."1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited passage

Welcome to the new Questia Reader

The Questia Reader has been updated to provide you with an even better online reading experience.  It is now 100% Responsive, which means you can read our books and articles on any sized device you wish.  All of your favorite tools like notes, highlights, and citations are still here, but the way you select text has been updated to be easier to use, especially on touchscreen devices.  Here's how:

1. Click or tap the first word you want to select.
2. Click or tap the last word you want to select.

OK, got it!

Thanks for trying Questia!

Please continue trying out our research tools, but please note, full functionality is available only to our active members.

Your work will be lost once you leave this Web page.

For full access in an ad-free environment, sign up now for a FREE, 1-day trial.

Already a member? Log in now.